223 related articles for article (PubMed ID: 32853246)
1. Substance use service availability in HIV treatment programs: Data from the global IeDEA consortium, 2014-2015 and 2017.
Parcesepe AM; Lancaster K; Edelman EJ; DeBoni R; Ross J; Atwoli L; Tlali M; Althoff K; Tine J; Duda SN; Wester CW; Nash D;
PLoS One; 2020; 15(8):e0237772. PubMed ID: 32853246
[TBL] [Abstract][Full Text] [Related]
2. Availability of substance use screening and treatment within HIV clinical sites across seven geographic regions within the IeDEA consortium.
Lancaster KE; Stockton M; Remch M; Wester CW; Nash D; Brazier E; Adedimeji A; Finlayson R; Freeman A; Hogan B; Kasozi C; Kwobah EK; Kulzer JL; Merati T; Tine J; Poda A; Succi R; Twizere C; Tlali M; Groote PV; Edelman EJ; Parcesepe AM;
Int J Drug Policy; 2024 Feb; 124():104309. PubMed ID: 38228025
[TBL] [Abstract][Full Text] [Related]
3. Screening and management of mental health and substance use disorders in HIV treatment settings in low- and middle-income countries within the global IeDEA consortium.
Parcesepe AM; Mugglin C; Nalugoda F; Bernard C; Yunihastuti E; Althoff K; Jaquet A; Haas AD; Duda SN; Wester CW; Nash D;
J Int AIDS Soc; 2018 Mar; 21(3):e25101. PubMed ID: 29603887
[TBL] [Abstract][Full Text] [Related]
4. Availability of screening and treatment for common mental disorders in HIV clinic settings: data from the global International epidemiology Databases to Evaluate AIDS (IeDEA) Consortium, 2016-2017 and 2020.
Parcesepe AM; Stockton M; Remch M; Wester CW; Bernard C; Ross J; Haas AD; Ajeh R; Althoff KN; Enane L; Pape W; Minga A; Kwobah E; Tlali M; Tanuma J; Nsonde D; Freeman A; Duda SN; Nash D; Lancaster K;
J Int AIDS Soc; 2023 Aug; 26(8):e26147. PubMed ID: 37535703
[TBL] [Abstract][Full Text] [Related]
5. Integrating screening, brief intervention, and referral to treatment (SBIRT) into clinical practice settings: a brief review.
Agerwala SM; McCance-Katz EF
J Psychoactive Drugs; 2012; 44(4):307-17. PubMed ID: 23210379
[TBL] [Abstract][Full Text] [Related]
6. Design and implementation of a global site assessment survey among HIV clinics participating in the International epidemiology Databases to Evaluate AIDS (IeDEA) research consortium.
Brazier E; Maruri F; Wester CW; Musick B; Freeman A; Parcesepe A; Hossmann S; Christ B; Kimmel A; Humphrey J; Freeman E; Enane LA; Lancaster KE; Ballif M; Golub JE; Nash D; Duda SN;
PLoS One; 2023; 18(3):e0268167. PubMed ID: 36917598
[TBL] [Abstract][Full Text] [Related]
7. Implementation of "Treat-all" at adult HIV care and treatment sites in the Global IeDEA Consortium: results from the Site Assessment Survey.
Brazier E; Maruri F; Duda SN; Tymejczyk O; Wester CW; Somi G; Ross J; Freeman A; Cornell M; Poda A; Musick BS; Zhang F; Althoff KN; Mugglin C; Kimmel AD; Yotebieng M; Nash D;
J Int AIDS Soc; 2019 Jul; 22(7):e25331. PubMed ID: 31623428
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of U.S. Substance Abuse Treatment Facilities Offering HIV Services: Results From a National Survey.
Cohn A; Stanton C; Elmasry H; Ehlke S; Niaura R
Psychiatr Serv; 2016 Jun; 67(6):692-5. PubMed ID: 26975517
[TBL] [Abstract][Full Text] [Related]
9. Comprehensiveness of HIV care provided at global HIV treatment sites in the IeDEA consortium: 2009 and 2014.
Fritz CQ; Blevins M; Lindegren ML; Wools-Kaloutsian K; Musick BS; Cornell M; Goodwin K; Addison D; Dusingize JC; Messou E; Poda A; Duda SN; McGowan CC; Law MG; Moore RD; Freeman A; Nash D; Wester CW
J Int AIDS Soc; 2017 Jan; 20(1):20933. PubMed ID: 28364561
[TBL] [Abstract][Full Text] [Related]
10. Service delivery challenges in HIV care during the first year of the COVID-19 pandemic: results from a site assessment survey across the global IeDEA consortium.
Brazier E; Ajeh R; Maruri F; Musick B; Freeman A; Wester CW; Lee MP; Shamu T; Crabtree Ramírez B; d'Almeida M; Wools-Kaloustian K; Kumarasamy N; Althoff KN; Twizere C; Grinsztejn B; Tanser F; Messou E; Byakwaga H; Duda SN; Nash D;
J Int AIDS Soc; 2022 Dec; 25(12):e26036. PubMed ID: 36504431
[TBL] [Abstract][Full Text] [Related]
11. Preexposure prophylaxis availability among health facilities participating in the global International epidemiology Databases to Evaluate AIDS (IeDEA) consortium.
Kebede S; Brazier E; Freeman AM; Muwonge TR; Choi JY; de Waal R; Poda A; Cesar C; Munyaneza A; Kasozi C; Pasayan MKU; Althoff KN; Shongo A; Low N; Ekouevi D; Veloso VG; Ross J;
AIDS; 2024 Apr; 38(5):751-756. PubMed ID: 38133656
[TBL] [Abstract][Full Text] [Related]
12. Availability of HIV-related health services in adolescent substance abuse treatment programs.
Knudsen HK; Oser CB
AIDS Care; 2009 Oct; 21(10):1238-46. PubMed ID: 20024699
[TBL] [Abstract][Full Text] [Related]
13. Nurses decrease barriers to health care by "hyperlinking" multiple-diagnosed women living with HIV/AIDS into care.
Andersen MD; Smereck GA; Hockman EM; Ross DJ; Ground KJ
J Assoc Nurses AIDS Care; 1999; 10(2):55-65. PubMed ID: 10065410
[TBL] [Abstract][Full Text] [Related]
14. Provision of onsite HIV Services in Substance Use Disorder Treatment Programs: A Longitudinal Analysis.
Aletraris L; Roman PM
J Subst Abuse Treat; 2015 Oct; 57():1-8. PubMed ID: 25934459
[TBL] [Abstract][Full Text] [Related]
15. On-site HIV testing in residential drug treatment units: results of a nationwide survey.
Strauss SM; Des Jarlais DC; Astone J; Vassilev ZP
Public Health Rep; 2003; 118(1):37-43. PubMed ID: 12604763
[TBL] [Abstract][Full Text] [Related]
16. Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study.
Desmonde S; Tanser F; Vreeman R; Takassi E; Edmonds A; Lumbiganon P; Pinto J; Malateste K; McGowan C; Kariminia A; Yotebieng M; Dicko F; Yiannoutsos C; Mubiana-Mbewe M; Wools-Kaloustian K; Davies MA; Leroy V;
PLoS Med; 2018 May; 15(5):e1002565. PubMed ID: 29727458
[TBL] [Abstract][Full Text] [Related]
17. Substance Use Screening in HIV Care Settings: a Review and Critique of the Literature.
Hitch AE; Gause NK; Brown JL
Curr HIV/AIDS Rep; 2019 Feb; 16(1):7-16. PubMed ID: 30747409
[TBL] [Abstract][Full Text] [Related]
18. Provision of and Barriers to Integrating Reproductive and Sexual Health Services for Reproductive-age Women in Opioid Treatment Programs.
Klaman SL; Lorvick J; Jones HE
J Addict Med; 2019; 13(6):422-429. PubMed ID: 31689259
[TBL] [Abstract][Full Text] [Related]
19. A cross-site, comparative effectiveness study of an integrated HIV and substance use treatment program.
Proeschold-Bell RJ; Heine A; Pence BW; McAdam K; Quinlivan EB
AIDS Patient Care STDS; 2010 Oct; 24(10):651-8. PubMed ID: 20846009
[TBL] [Abstract][Full Text] [Related]
20. Utilization of mental health and substance abuse care for people living with HIV/AIDS, chronic mental illness, and substance abuse disorders.
Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Ettner SL;
J Acquir Immune Defic Syndr; 2008 Apr; 47(4):449-58. PubMed ID: 18197121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
